Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06666192 · ClinicalTrials.gov registry record · NA

The Ohio State University (OSU) SCREEN Community Program

A NA study of Breast Carcinoma and Colorectal Carcinoma, sponsored by Ohio State University Comprehensive Cancer Center.

Recruiting
Registry status
NA
Development phase
2,067
Enrollment target
1
Study location

NCT06666192 is a NA study of Breast Carcinoma and Colorectal Carcinoma that is actively recruiting participants, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 2,067 participants, above the 751-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (175% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06666192, a NA study of Breast Carcinoma and Colorectal Carcinoma, is actively recruiting participants, sponsored by Ohio State University Comprehensive Cancer Center.

RECRUITING
Registry status
NA
Development phase
2,067 participants
Enrollment target
1
Study location

Study Summary

This clinical trial develops and tests how well a multi-level intervention (MLI), The Ohio State University (OSU) SCREEN Community Program, works to increase screening and follow-up for breast, cervical and colorectal (CRC) cancer among low-income and un/underinsured female residents in three counties in Central Ohio. In Ohio, incidence and mortality rates for breast, cervical and CRC are higher than or similar to the national average; in addition, underserved populations - minority, rural and low-income women - have higher rates of these cancers. Screening can detect precancerous colorectal and cervical lesions and other early-stage cancers when treatment is less intensive and more successful and is known to reduce mortality rates for breast, cervical, and CRC, however many of these women lack access to health care and screenings. This MLI includes clinic-based components, such as patient education, as well as community-based strategies, such as media programs and training health workers, that can increase rates of guideline-recommended breast, cervical and CRC screening and follow-ups in underserved populations. The OSU SCREEN Community Program may be an effective way to improve breast, cervical and CRC screenings among underserved women in Ohio.

Interventions

  • OTHER Educational Intervention
  • OTHER Discussion
  • BEHAVIORAL Focus Group
  • OTHER Educational Activity
  • OTHER Cancer Screening

Study Locations (1)

Ohio

  • Ohio State University Comprehensive Cancer Center - Columbus

Trial Details

FieldValue
Enrollment Target 2,067 participants
Start Date 2024-03-12
Est. Completion 2029-12-31
Phase NA

What the Registry Record Tells You About NCT06666192

The ClinicalTrials.gov registry entry for NCT06666192 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 2,067 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 751-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (175% higher). The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Breast Carcinoma appearing as the primary indexed condition, and to 5 interventions - of which Educational Intervention is the first listed.

NCT06666192 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT06666192 about?

NCT06666192 is a clinical study titled "The Ohio State University (OSU) SCREEN Community Program". This clinical trial develops and tests how well a multi-level intervention (MLI), The Ohio State University (OSU) SCREEN Community Program, works to increase screening and follow-up for breast, cervical and colorectal (CRC) cancer among low-income and un/underinsured female residents in three counti...

What is the current status of trial NCT06666192?

This trial is currently recruiting. It is a NA study. The enrollment target is 2,067 participants. The study started on 2024-03-12. Estimated completion is 2029-12-31.

What conditions does trial NCT06666192 study?

This clinical trial studies the following conditions: Breast Carcinoma, Colorectal Carcinoma, Cervical Carcinoma.

What interventions are being tested in trial NCT06666192?

The interventions under investigation include: Educational Intervention (OTHER), Discussion (OTHER), Focus Group (BEHAVIORAL), Educational Activity (OTHER), Cancer Screening (OTHER).

Who is sponsoring clinical trial NCT06666192?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06666192 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.